Table 1.
Enrolled patient characteristics.
| All N = 100 |
1*/1* N = 47 |
*1/*28 N = 43 |
*28/*28 N = 10 |
||
|---|---|---|---|---|---|
| Age median (range) | 58 (19-79) | 59 (38-79) | 59 (19-72) | 62 (52- 76) | |
| Female n (%) | 48 (48%) | 22 (47%) | 18 (42%) | 8 (80%) | |
| Race | Black | 12 (12%) | 3 (6%) | 7 (16%) | 2 (20%) |
| White | 83 (83%) | 40 (85%) | 35 (81%) | 8 (80%) | |
| Sites of metastatic disease | 1 | 41 (41%) | 20 (43%) | 18 (42%) | 3 (30%) |
| ≥ 2 | 59 (59%) | 27 (57%) | 25 (58%) | 7 (70%) | |
| Somatic mutation | |||||
| KRAS or NRAS Mutated | 28 (28%) | 9 (19%) | 13 (30%) | 5 (50%) | |
| BRAF V600E | 8 (8%) | 6 (13%) | 2 (5%) | 0 (0%) |